The co-occurrence of symptoms was examined through a cluster analysis, which mapped connections between side effects frequently mentioned together, helping to identify common symptom groupings
The protein content in GLP-1 Protein+ addresses the widely observed drop in protein consumption among users of GLP-1 treatments
Expert Opin Investig Drugs 32(5):355359 Urva S, Coskun T, Loh MT, Du Y, Thomas MK, Gurbuz S et al (2022) LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Bush Hoffmann U, Fischereder M, Kruger B, Drobnik W, Kramer BK
Tirzepatide with niacinamide Tirzepatide with niacinamide targets metabolic health and skin support